- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/07 - Vaccinia virusVariola virus
Patent holdings for IPC class C07K 14/07
Total number of patents in this class: 57
10-year publication summary
|
1
|
3
|
0
|
5
|
6
|
7
|
2
|
0
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bavarian Nordic A/S | 257 |
8 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 367 |
5 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3143 |
5 |
| Ottawa Hospital Research Institute | 109 |
4 |
| Memorial Sloan-Kettering Cancer Center | 1925 |
2 |
| Provincial Health Services Authority | 186 |
2 |
| UVic Industry Partnerships Inc. | 104 |
2 |
| BioNTech SE | 657 |
2 |
| Turnstone Biologics Corp. | 21 |
2 |
| Centre National de La Recherche Scientifique | 10418 |
1 |
| 13THERAPEUTICS, Inc. | 5 |
1 |
| Cellscript, Inc. | 3 |
1 |
| Centre for Drug Research and Development | 20 |
1 |
| City of Hope | 988 |
1 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1366 |
1 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1537 |
1 |
| Garvan Institute of Medical Research | 68 |
1 |
| Genelux Corporation | 30 |
1 |
| Heptares Therapeutics Limited | 77 |
1 |
| Institut Pasteur | 785 |
1 |
| Other owners | 14 |